Impact of the new kidney allocation system A2/A2B → B policy on access to transplantation among minority candidates

Blood group B candidates, many of whom represent ethnic minorities, have historically had diminished access to deceased donor kidney transplantation (DDKT). The new national kidney allocation system (KAS) preferentially allocates blood group A2/A2B deceased donor kidneys to B recipients to address this ethnic and blood group disparity. No study has yet examined the impact of KAS on A2 incompatible (A2i) DDKT for blood group B recipients overall or among minorities. A case‐control study of adult blood group B DDKT recipients from 2013 to 2017 was performed, as reported to the Scientific Registry of Transplant Recipients. Cases were defined as recipients of A2/A2B kidneys, whereas controls were all remaining recipients of non‐A2/A2B kidneys. A2i DDKT trends were compared from the pre‐KAS (1/1/2013‐12/3/2014) to the post‐KAS period (12/4/2014‐2/28/2017) using multivariable logistic regression. Post‐KAS, there was a 4.9‐fold increase in the likelihood of A2i DDKT, compared to the pre‐KAS period (odds ratio [OR] 4.92, 95% confidence interval [CI] 3.67‐6.60). However, compared to whites, there was no difference in the likelihood of A2i DDKT among minorities post‐KAS. Although KAS resulted in increasing A2/A2B→B DDKT, the likelihood of A2i DDKT among minorities, relative to whites, was not improved. Further discussion regarding A2/A2B→B policy revisions aiming to improve DDKT access for minorities is warranted.

[1]  J. Hockenberry,et al.  New Kidney Allocation System Associated With Increased Rates Of Transplants Among Black And Hispanic Patients. , 2017, Health affairs.

[2]  M. Zeier,et al.  ABO-Incompatible Kidney Transplantation , 2017, Front. Immunol..

[3]  A. Israni,et al.  OPTN/SRTR 2015 Annual Data Report: Early effects of the new kidney allocation system , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[4]  D. Segev,et al.  Early Changes in Kidney Distribution under the New Allocation System. , 2016, Journal of the American Society of Nephrology : JASN.

[5]  I. Feurer,et al.  A2 incompatible kidney transplantation does not adversely affect graft or patient survival , 2016, Clinical transplantation.

[6]  C. Young,et al.  First Report on the OPTN National Variance: Allocation of A2/A2B Deceased Donor Kidneys to Blood Group B Increases Minority Transplantation , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[7]  E. Milford,et al.  Racial and ethnic disparities in kidney transplantation , 2011, Transplant international : official journal of the European Society for Organ Transplantation.

[8]  E. Elster,et al.  Transplantation of A2 Kidneys into B and O Recipients Leads to Reduction in Waiting Time: USRDS Experience , 2010, Transplantation.

[9]  M. Breimer,et al.  Blood Group A and B Antigen Expression in Human Kidneys Correlated to A1/A2/B, Lewis, and Secretor Status , 2006, Transplantation.

[10]  F. Winklhofer,et al.  Improving Access to Kidney Transplantation without Decreasing Graft Survival: Long-Term Outcomes of Blood Group A2/A2B Deceased Donor Kidneys in B Recipients , 2005, Transplantation.

[11]  T. Larson,et al.  ABO-incompatible kidney transplantation using both A2 and non-A2 living donors , 2003, Transplantation.

[12]  C. Bryan,et al.  Increased Access to Transplantation for Blood Group B Cadaveric Waiting List Candidates by Using A2 Kidneys: Time for a New National System? , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[13]  C. Young,et al.  Renal transplantation in black Americans. , 2000, The New England journal of medicine.

[14]  P. Cleary,et al.  Racial disparities in access to renal transplantation--clinically appropriate or due to underuse or overuse? , 2000, The New England journal of medicine.